Protara Therapeutics (TARA)
(Real Time Quote from BATS)
$2.31 USD
+0.02 (0.87%)
Updated Jul 26, 2024 02:58 PM ET
3-Hold of 5 3
D Value F Growth D Momentum F VGM
Cash flow Statements
Fiscal Year End for Protara Therapeutics, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -40.42 | -65.95 | -47.25 | -33.98 | -14.99 |
Depreciation/Amortization & Depletion | 0.91 | 32.27 | 1.85 | 0.20 | 0.28 |
Net Change from Assets/Liabilities | -4.14 | 0.54 | 0.53 | 0.63 | -1.87 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 6.09 | 6.69 | 10.36 | 9.75 | 0.94 |
Net Cash From Operating Activities | -37.56 | -26.46 | -34.50 | -23.41 | -15.65 |
Property & Equipment | -0.05 | -0.12 | -0.60 | -0.88 | -0.02 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 53.15 | 15.07 | -97.60 | 0.00 | 2.50 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 3.72 | 0.00 |
Net Cash from Investing Activities | 53.11 | 14.95 | -98.19 | 2.84 | 2.48 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.00 | 0.00 | 0.00 | 0.53 | 0.00 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 11.09 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | -1.67 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -0.09 | -0.09 | -0.23 | 179.45 | 0.00 |
Net Cash from Financing Activities | -0.09 | -0.09 | -0.23 | 189.40 | 0.00 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | 15.46 | -11.60 | -132.92 | 168.83 | -13.16 |
Cash at Beginning of Period | 24.87 | 36.47 | 169.39 | 0.56 | 19.39 |
Cash at End of Period | 40.33 | 24.87 | 36.47 | 169.39 | 6.23 |
Diluted Net EPS | -3.57 | -5.86 | -4.21 | -4.70 | -30.15 |
Fiscal Year End for Protara Therapeutics, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -11.10 | -40.42 | -30.20 | -20.34 |
Depreciation/Amortization & Depletion | NA | 0.26 | 0.91 | -0.10 | -0.05 |
Net Change from Assets/Liabilities | NA | -0.77 | -4.14 | -3.20 | -5.10 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 1.23 | 6.09 | 4.64 | 3.19 |
Net Cash From Operating Activities | NA | -10.38 | -37.56 | -28.86 | -22.30 |
Property & Equipment | NA | 0.00 | -0.05 | -0.05 | -0.01 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | 23.10 | 53.15 | 38.63 | 32.22 |
Other Investing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | NA | 23.10 | 53.11 | 38.59 | 32.21 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Issuance (Repayment) of Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | -0.08 | -0.09 | -0.09 | -0.06 |
Net Cash from Financing Activities | NA | -0.08 | -0.09 | -0.09 | -0.06 |
Effect of Exchange Rate Changes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | NA | 12.65 | 15.46 | 9.64 | 9.85 |
Cash at Beginning of Period | NA | 40.33 | 24.87 | 24.87 | 24.87 |
Cash at End of Period | NA | 52.98 | 40.33 | 34.51 | 34.72 |
Diluted Net EPS | NA | -0.97 | -0.90 | -0.87 | -1.00 |